Douglas J. Swirsky
2018
In 2018, Douglas J. Swirsky earned a total compensation of $1.2M as President and Chief Executive Officer at Rexahn Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $106,250 |
|---|---|
| Option Awards | $703,977 |
| Salary | $359,952 |
| Other | $14,175 |
| Total | $1,184,354 |
Swirsky received $704K in option awards, accounting for 59% of the total pay in 2018.
Swirsky also received $106.3K in non-equity incentive plan, $360K in salary and $14.2K in other compensation.
Rankings
In 2018, Douglas J. Swirsky's compensation ranked 8,349th out of 14,244 executives tracked by ExecPay. In other words, Swirsky earned more than 41.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,349 out of 14,244 | 41st |
Division Manufacturing | 3,311 out of 5,765 | 43rd |
Major group Chemicals And Allied Products | 1,243 out of 2,128 | 42nd |
Industry group Drugs | 1,039 out of 1,817 | 43rd |
Industry Pharmaceutical Preparations | 810 out of 1,391 | 42nd |
Source: SEC filing on April 29, 2019.
Swirsky's colleagues
We found three more compensation records of executives who worked with Douglas J. Swirsky at Rexahn Pharmaceuticals in 2018.